At the American Society of Nephrology (ASN) Kidney Week meeting, an interim analysis of a phase III trial of sibeprenlimab in immunoglobulin A (IgA) nephropathy showed a nearly 50% reduction in ...

Purpose Toxic shock syndrome (TSS) is a rare disease responsible for significant morbidity and mortality. Intravenous immunoglobulin (IG) therapy in paediatric TSS could improve shock and organ ...

IG (LSEG:IGG), a trading and investments platform, has selected investment infrastructure provider Upvest to power its stock ...

CSL said the investment reflects the growing need for immunoglobulin, though it did not reveal detailed manufacturing plans.

Polycystic kidney disease (PKD) is a debilitating hereditary condition in which fluid-filled sacs form and proliferate in the ...

A specially engineered antibody that can infiltrate kidney cysts has shown the ability to block key growth signals driving ...

IG Group Holdings ( ($GB:IGG) ) has provided an announcement. IG Group Holdings plc announced the purchase of 112,386 of its ordinary shares from ...

Takenobu Y, Kikuchi T, Ishikawa D, et al. Rozanolixizumab as rescue therapy in triple seronegative refractory generalized ...

Australia’s CSL has announced plans to expand its US presence over the next five years, resulting in approximately $1.5 ...

The MarketWatch News Department was not involved in the creation of this content.-- Omlyclo(TM) (omalizumab) is the first and only omalizumab biosimilar approved in Europe -- Omly ...

Builds on company’s more than $3b U.S. investment since 2018 which created thousands of new jobs across 44 states ...

The European Commission (EC) has granted a line extension in the European Union (EU) for Celltrion’s Omlyclo™ (omalizumab), ...